|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
355,150,000 |
Market
Cap: |
2.33(B) |
Last
Volume: |
17,273,575 |
Avg
Vol: |
17,226,422 |
52
Week Range: |
$6.13 - $10.61 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 400 MIDCAP |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Bausch Health Companies develops, manufactures and markets, primarily in the therapeutic areas of eye-health, gastroenterology and dermatology, a range of: pharmaceuticals, generic and branded generic pharmaceuticals, over-the-counter (OTC) products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices). Co.'s portfolio of products falls into four operating and reportable segments: Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
6,313 |
6,533 |
13,261 |
14,828 |
Total Sell Value |
$61,867 |
$63,491 |
$119,170 |
$133,715 |
Total People Sold |
1 |
1 |
1 |
1 |
Total Sell Transactions |
1 |
2 |
4 |
7 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Wechsler Amy B |
Director |
|
2019-09-30 |
4 |
A |
$21.85 |
$31,857 |
D/D |
1,458 |
87,809 |
|
- |
|
Robertson Russel C |
Director |
|
2019-09-30 |
4 |
A |
$21.85 |
$37,495 |
D/D |
1,716 |
92,730 |
|
- |
|
Papa Joseph C |
CHAIRMAN & CEO |
|
2019-09-16 |
4 |
D |
$23.24 |
$118,873 |
D/D |
(5,115) |
855,734 |
|
- |
|
Herendeen Paul |
EVP and CFO |
|
2019-09-16 |
4 |
D |
$23.24 |
$38,160 |
D/D |
(1,642) |
253,718 |
|
- |
|
Papa Joseph C |
CHAIRMAN & CEO |
|
2019-09-13 |
4 |
A |
$0.00 |
$0 |
D/D |
21,248 |
860,849 |
|
- |
|
Papa Joseph C |
CHAIRMAN & CEO |
|
2019-09-13 |
4 |
B |
$23.31 |
$699,300 |
D/D |
30,000 |
839,601 |
2.81 |
- |
|
Herendeen Paul |
EVP and CFO |
|
2019-08-23 |
4 |
D |
$22.40 |
$551,600 |
D/D |
(24,625) |
255,360 |
|
- |
|
Mckenna Mark C. |
President, Salix |
|
2019-08-19 |
4 |
S |
$21.83 |
$235,221 |
D/D |
(10,773) |
20,756 |
|
- |
|
Appio Thomas |
Pres&Co-Head Bausch&Lomb/Intl |
|
2019-08-19 |
4 |
D |
$21.30 |
$178,111 |
D/D |
(8,362) |
162,681 |
|
- |
|
Humphries William D. |
President, Ortho-Dermatologics |
|
2019-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
30,703 |
178,424 |
|
- |
|
Humphries William D. |
President, Ortho-Dermatologics |
|
2019-08-16 |
4 |
B |
$21.18 |
$650,142 |
D/D |
30,703 |
147,721 |
2.74 |
- |
|
Ackermann Christina |
EVP AND GENERAL COUNSEL |
|
2019-08-12 |
4 |
AS |
$22.45 |
$76,726 |
D/D |
(3,418) |
50,525 |
|
- |
|
Ackermann Christina |
EVP AND GENERAL COUNSEL |
|
2019-08-09 |
4 |
D |
$22.39 |
$174,172 |
D/D |
(7,779) |
53,943 |
|
- |
|
Ackermann Christina |
EVP AND GENERAL COUNSEL |
|
2019-07-11 |
4 |
AS |
$24.81 |
$98,446 |
D/D |
(3,968) |
61,722 |
|
- |
|
Wechsler Amy B |
Director |
|
2019-06-28 |
4 |
A |
$25.22 |
$31,853 |
D/D |
1,263 |
86,351 |
|
- |
|
Robertson Russel C |
Director |
|
2019-06-28 |
4 |
A |
$25.22 |
$37,477 |
D/D |
1,486 |
91,014 |
|
- |
|
De Schutter Richard U |
Director |
|
2019-06-28 |
4 |
A |
$25.22 |
$31,248 |
D/D |
1,239 |
271,776 |
|
- |
|
Paulson John |
Director |
|
2019-06-28 |
4 |
A |
$25.22 |
$27,490 |
D/D |
1,090 |
53,535 |
|
- |
|
Mckenna Mark C. |
President, Salix |
|
2019-06-24 |
4 |
D |
$23.82 |
$45,568 |
D/D |
(1,913) |
31,529 |
|
- |
|
Valueact Holdings Gp, Llc |
See Remarks |
|
2019-06-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(111,440) |
948,353 |
|
- |
|
Eldessouky Sam |
SVP, CHIEF ACCOUNTING OFFICER |
|
2019-06-04 |
4 |
D |
$20.73 |
$132,050 |
D/D |
(6,370) |
61,444 |
|
- |
|
Gordon Joseph F |
Pres&Co-Head Bausch&Lomb/Intl |
|
2019-05-06 |
4 |
D |
$23.51 |
$16,292 |
D/D |
(693) |
51,196 |
|
- |
|
Mckenna Mark C. |
President, Salix |
|
2019-05-06 |
4 |
D |
$23.51 |
$17,538 |
D/D |
(746) |
33,442 |
|
- |
|
Kavanagh Sarah B |
Director |
|
2019-05-03 |
4 |
A |
$23.51 |
$249,982 |
D/D |
10,633 |
64,378 |
|
- |
|
De Schutter Richard U |
Director |
|
2019-05-03 |
4 |
A |
$23.51 |
$249,982 |
D/D |
10,633 |
270,537 |
|
- |
|
1058 Records found
|
|
Page 15 of 43 |
|
|